Guttman-Yassky, E. ., Brunner, P. ., Neumann, A. ., Khattri, S. ., Pavel, A. ., Malik, K. ., … Lebwohl, M. . (2018). Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2018.01.016 (Original work published 2018)